DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Stock Price, Quote, News and Overview
TSX:CARE - Toronto Stock Exchange - CA25249F1045 - Common Stock - Currency: CAD
CARE.CA Quote, Performance and Key Statistics
TSX:CARE (10/4/2023, 7:00:00 PM)
5.14
+0 (+0.1%)
The current stock price of CARE.CA is 5.14 CAD. In the past month the price increased by 0.39%. In the past year, price increased by 117.8%.
CARE.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.32B | ||
| AND.CA | ANDLAUER HEALTHCARE GROUP IN | 33.26 | 2.08B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 20.9 | 1.54B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.18B | ||
| AIDX.CA | HEALWELL AI INC | N/A | 390.24M | ||
| QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 116.12M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | 26.5 | 23.14M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 14.72M | ||
| ARC.CA | ARCPOINT INC | 1.83 | 7.06M | ||
| PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 2.22M |
Related stock screener links
About CARE.CA
Company Profile
Dialogue Health Technologies, Inc. operates as a health and wellness platform. The company is headquartered in Montreal, Quebec and currently employs 240 full-time employees. The company went IPO on 2021-03-30. The firm provides a digital healthcare and wellness platform, namely the Integrated Health Platform. The Company’s Integrated Health Platform is a healthcare hub that centralizes all its programs in a single application by providing access to service all the 365 days through a smartphone, computer or tablet. Through the Company’s vertically integrated platform, its members and their dependents have access to a team of multidisciplinary professionals who treats physical and mental health conditions as well as other wellness services. The company also offers its members and their dependents access to an employee assistance program (EAP), as well as an Internet-based cognitive behavioral therapy (iCBT) program. Its wellness program includes clinically reviewed content, wellness challenges (integrated with wearable technology) and healthy habits, to help members sleep better, reduce stress, improve fitness and nutrition.
Company Info
DIALOGUE HEALTH TECHNOLOGIES
390 Notre-Dame W, Suite 200
MONTREAL QUEBEC H2Y 1T9 CA
CEO: Cherif Habib
Employees: 240
DIALOGUE HEALTH TECHNOLOGIES / CARE.CA FAQ
What is the stock price of DIALOGUE HEALTH TECHNOLOGIES today?
The current stock price of CARE.CA is 5.14 CAD. The price increased by 0.1% in the last trading session.
What is the ticker symbol for DIALOGUE HEALTH TECHNOLOGIES stock?
The exchange symbol of DIALOGUE HEALTH TECHNOLOGIES is CARE and it is listed on the Toronto Stock Exchange exchange.
On which exchange is CARE.CA stock listed?
CARE.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for DIALOGUE HEALTH TECHNOLOGIES stock?
12 analysts have analysed CARE.CA and the average price target is 5.09 CAD. This implies a price decrease of -1.03% is expected in the next year compared to the current price of 5.14. Check the DIALOGUE HEALTH TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DIALOGUE HEALTH TECHNOLOGIES worth?
DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) has a market capitalization of 346.67M CAD. This makes CARE.CA a Small Cap stock.
How many employees does DIALOGUE HEALTH TECHNOLOGIES have?
DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) currently has 240 employees.
What are the support and resistance levels for DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) stock?
DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) has a support level at 5.13 and a resistance level at 5.15. Check the full technical report for a detailed analysis of CARE.CA support and resistance levels.
Is DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) expected to grow?
The Revenue of DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) is expected to grow by 15.01% in the next year. Check the estimates tab for more information on the CARE.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CARE.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CARE.CA, evaluating the profitability, health, valuation and growth aspects
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Sales and EPS estimates to see what analysts future expectations are.
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Stock Chart to make your own analysis
- DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) Latest news and press-releases to stay up to date.
Does DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) stock pay dividends?
CARE.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of DIALOGUE HEALTH TECHNOLOGIES (CARE.CA)?
DIALOGUE HEALTH TECHNOLOGIES (CARE.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
CARE.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CARE.CA. When comparing the yearly performance of all stocks, CARE.CA is one of the better performing stocks in the market, outperforming 98.49% of all stocks.
CARE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CARE.CA. The financial health of CARE.CA is average, but there are quite some concerns on its profitability.
CARE.CA Financial Highlights
Over the last trailing twelve months CARE.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 29.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.93% | ||
| ROE | -20.81% | ||
| Debt/Equity | 0.01 |
CARE.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to CARE.CA. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 54.37% and a revenue growth 15.01% for CARE.CA